Related Experiment Video
Updated: Aug 14, 2026

Visualization of G3BP Stress Granules Dynamics in Live Primary Cells
Published on: May 21, 2014
Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin
Denise M Ferkey1, David Kimelman
1Department of Biochemistry and Center for Developmental Biology, University of Washington, Seattle, Washington 98195-7350, USA.
Abstract:
Glycogen synthase kinase-3 beta (GSK-3) is a key downstream target of Wnt signaling and is regulated by its interactions with activating and inhibitory proteins. We and others have shown that GSK-3 activity toward non-primed substrates is regulated in part through a competition between its activating (Axin) and inhibitory (GBP/FRAT) binding partners. Here we use a reverse two-hybrid screen to identify mutations in GSK-3 that alter binding to GBP and Axin. We find that these mutations overlap and propose that GBP and Axin compete for binding to the same region of GSK-3. We use these mutations to examine the ability of GSK-3 to block eye development in Xenopus embryos and suggest that GSK-3 regulates eye development through a non-Wnt pathway.
Insights
Glycogen synthase kinase-3 beta (GSK-3) binding proteins Axin and GBP compete for the same site. Mutations altering this interaction affect GSK-3
Area of Science:
- Molecular Biology
- Developmental Biology
- Biochemistry
Background:
- Glycogen synthase kinase-3 beta (GSK-3) is a crucial Wnt signaling pathway target.
- GSK-3 activity is modulated by interactions with activating (Axin) and inhibitory (GBP/FRAT) proteins.
- Protein binding competition regulates GSK-3 activity on non-primed substrates.
Purpose of the Study:
- Identify GSK-3 mutations affecting GBP and Axin binding using a reverse two-hybrid screen.
- Investigate the functional consequences of these mutations on GSK-3 activity and developmental processes.
- Determine if GSK-3 regulates Xenopus eye development via Wnt-dependent or independent pathways.
Main Methods:
- Reverse two-hybrid screening to identify GSK-3 binding mutants.
- Biochemical assays to confirm altered binding affinities.
- Xenopus embryo manipulation to assess developmental roles.
Main Results:
- Identified overlapping mutations in GSK-3 that alter binding to both GBP and Axin.
- Mutations suggest GBP and Axin compete for the same binding region on GSK-3.
- GSK-3 mutations impact Xenopus eye development, indicating a non-Wnt pathway involvement.
Conclusions:
- GSK-3, Axin, and GBP interact at a common binding site.
- GSK-3 plays a role in Xenopus eye development independent of the Wnt pathway.
- Understanding GSK-3 binding dynamics offers insights into developmental regulation.
Related Concept Videos
GTPases and their Regulation
Large G-proteins, also known...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Activation and Inactivation of G Proteins

